Mario R Romano1, Ugo Cipollone2, Francesco Semeraro3, Michele Rinaldi4, Ciro Costagliola11Dipartimento di Scienze per la Salute, Università degli Studi del Molise, Campobasso; 2Dipartimento di Oftalmologia, Ospedale G Vietri, Larino ...
Mario R Romano +3 more
doaj
Severe Polypoidal Choroidal Vasculopathy as a Harbinger of Spontaneous Suprachoroidal Hemorrhage. [PDF]
Tao BK +7 more
europepmc +1 more source
Correction: Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source
Long-Term Management of Polypoidal Choroidal Vasculopathy: A Narrative Review. [PDF]
Koh A +6 more
europepmc +1 more source
Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. [PDF]
Giridhar A, Lekha T, Chandran K.
europepmc +1 more source
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source
Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]
Jeong S, Seong SH, Sagong M.
europepmc +1 more source
Choroidal changes correlate with type 1 neovascular activity in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. [PDF]
Huang X +7 more
europepmc +1 more source
Peripheral polypoidal choroidal vasculopathy
Tingkun Shi, Haoyu Chen
doaj +1 more source
Clinical Outcomes of High-Dose Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. [PDF]
Bousamri A +6 more
europepmc +1 more source

